Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intrauma is an Italian orthopedic and traumatology medical device company that designs, manufactures, and commercializes internal fixation systems, intramedullary nails, and related surgical solutions for human and veterinary use. The company is best known for its O’nil range of locking internal fixators and also markets Elos and Elafix systems for long-bone fixation. Intrauma emphasizes in-house engineering, manufacturing, and quality control, with a vertically integrated model centered in the Turin area. Beyond core trauma implants, the company has expanded into regenerative medicine initiatives under the IntraGraft brand focused on autologous fat-based applications in orthopedics, sports medicine, and gynecology. Intrauma appears to be a private, active commercial-stage healthcare company with a strong presence in Italy and growing international distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intrauma.